专利检索 ap:("Chugai Seiyaku Kabushiki Kaisha" OR "Genentech, Inc.") AND inv:"Yoshinori Narita" 第 1 页

1.

发明授权
Methods of treating cancers using PD-1 axis binding antagonists and anti-GPC3 antibodies 有权

公开(公告)号：US11767362B1

公开(公告)日：2023-09-26

申请号：US16084346

申请日：2017-03-14

申请人： Chugai Seiyaku Kabushiki Kaisha , Genentech, Inc.

发明人： Mika Endo , Atsuhiko Kato , Toshihiko Ohtomo , Kenji Adachi , Yasuko Kinoshita , Yoshinori Narita

IPC分类号： C07K16/28 , C07K16/30 , A61P35/00

CPC分类号： C07K16/2827 , A61P35/00 , C07K16/303 , C07K2317/24 , C07K2317/54 , C07K2317/55 , C07K2317/56 , C07K2317/622 , C07K2317/76

摘要： The invention provides compositions and methods for treating cancers. The methods comprising administering a PD-1 axis binding antagonist and an anti-GPC3 antibody. The compositions comprising a pharmaceutical composition for treating cancer which comprises a PD-1 axis binding antagonist and an anti-GPC3 antibody. Also disclosed are a pharmaceutical composition to be used in combination with a PD-1 axis binding antagonist for treating cancer which comprises an anti-GPC3 antibody as the active ingredient; and a pharmaceutical composition to be used in combination with an anti-GPC3 antibody for treating cancer which comprises as the active ingredient a PD-1 axis binding antagonist.